NM_000520.6:c.1146+351G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_000520.6(HEXA):​c.1146+351G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0143 in 150,912 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.014 ( 54 hom., cov: 31)

Consequence

HEXA
NM_000520.6 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.427

Publications

1 publications found
Variant links:
Genes affected
HEXA (HGNC:4878): (hexosaminidase subunit alpha) This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
HEXA Gene-Disease associations (from GenCC):
  • Tay-Sachs disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 15-72347335-C-T is Benign according to our data. Variant chr15-72347335-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 1200011.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0143 (2154/150912) while in subpopulation AFR AF = 0.0497 (2050/41244). AF 95% confidence interval is 0.0479. There are 54 homozygotes in GnomAd4. There are 1000 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 54 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000520.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HEXA
NM_000520.6
MANE Select
c.1146+351G>A
intron
N/ANP_000511.2
HEXA
NM_001318825.2
c.1179+351G>A
intron
N/ANP_001305754.1
HEXA
NR_134869.3
n.1115+713G>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HEXA
ENST00000268097.10
TSL:1 MANE Select
c.1146+351G>A
intron
N/AENSP00000268097.6
HEXA
ENST00000567159.5
TSL:1
c.1146+351G>A
intron
N/AENSP00000456489.1
ENSG00000260729
ENST00000379915.4
TSL:2
n.413-1010G>A
intron
N/AENSP00000478716.1

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2150
AN:
150794
Hom.:
55
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0498
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00444
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.0107
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0143
AC:
2154
AN:
150912
Hom.:
54
Cov.:
31
AF XY:
0.0136
AC XY:
1000
AN XY:
73540
show subpopulations
African (AFR)
AF:
0.0497
AC:
2050
AN:
41244
American (AMR)
AF:
0.00444
AC:
67
AN:
15094
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5076
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4698
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10320
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67726
Other (OTH)
AF:
0.0105
AC:
22
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
86
172
259
345
431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0128
Hom.:
4
Bravo
AF:
0.0166

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.2
DANN
Benign
0.38
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60920713; hg19: chr15-72639676; API